Professor | Zheng Yang | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Zheng Yang
Contact Information	dr_yangzheng@whu.edu.cn
Language ability	Chinese, English
Province	Hubei

Upload Avatar (500 x 500)

Name

Zheng Yang

Contact Information

dr_yangzheng@whu.edu.cn

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	2003-2008 Bachelor of Clinical Medicine from Capital Medical University 2008-2011 Master of Internal Medicine from Beijing Institute of Heart, Lung and Blood Vessel Diseases 2011-2014 PhD in Internal Medicine from Wuhan University First Clinical College Has presided over multiple research grants including the National Natural Science Foundation
Work Experience	2014.07-2014.11 Resident Physician, Cardiovascular Department, Renmin Hospital, Wuhan University 2014.12-2018.10 Attending Physician, Cardiovascular Department, Renmin Hospital, Wuhan University 2018.11-present Associate Chief Physician, Cardiovascular Department, Renmin Hospital, Wuhan University 2021.05-present Associate Professor, Cardiovascular Department, Renmin Hospital, Wuhan University
Awards	2019 First Prize of Science and Technology Progress in Hubei Province for 'Structural Remodeling and Prevention of Heart Failure'

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

2003-2008 Bachelor of Clinical Medicine from Capital Medical University
2008-2011 Master of Internal Medicine from Beijing Institute of Heart, Lung and Blood Vessel Diseases
2011-2014 PhD in Internal Medicine from Wuhan University First Clinical College
Has presided over multiple research grants including the National Natural Science Foundation

Work Experience

2014.07-2014.11 Resident Physician, Cardiovascular Department, Renmin Hospital, Wuhan University
2014.12-2018.10 Attending Physician, Cardiovascular Department, Renmin Hospital, Wuhan University
2018.11-present Associate Chief Physician, Cardiovascular Department, Renmin Hospital, Wuhan University
2021.05-present Associate Professor, Cardiovascular Department, Renmin Hospital, Wuhan University

Awards

2019 First Prize of Science and Technology Progress in Hubei Province for 'Structural Remodeling and Prevention of Heart Failure'

Areas of Focus	Heart failure and cardiac remodeling pathophysiology and clinical prevention Interventional diagnosis and treatment of cardiovascular diseases
Publications	Aucubin Protects against Myocardial Infarction-Induced Cardiac Remodeling via nNOS/NO-Regulated Oxidative Stress, Yang Z, 2018 Sesamin prevents apoptosis and inflammation after experimental myocardial infarction by JNK and NF-κB pathways, Yang Z, 2017 Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy, Yang Z, 2017 Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway, Yang Z, 2017 A potential therapeutic approach to cardiac remodeling: JDP2, Yang Z, 2018 Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy, Yang Z, 2016 Naringenin attenuates pressure overload-induced cardiac hypertrophy, Yang Z, 2015 Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes, Yang Z, 2014 TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis, Yang Z, 2019 TLR9 deficiency alleviates doxorubicin-induced cardiotoxicity via the regulation of autophagy, Yang Z, 2020 The Role of PPARs in Pathological Cardiac Hypertrophy and Heart Failure, Yang Z, 2017 Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis, Yang Z, 2016 Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway, Yang Z, 2016 Mechanisms contributing to cardiac remodelling, Yang Z, 2017 BMI1 in the heart: Novel functions beyond tumorigenesis, Yang Z, 2021 The Roles of Noncardiomyocytes in Cardiac Remodeling, Yang Z, 2020 Critical roles of macrophages in pressure overload-induced cardiac remodeling, Yang Z, 2021 6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway, Yang Z, 2021

Areas of Focus

Heart failure and cardiac remodeling pathophysiology and clinical prevention
Interventional diagnosis and treatment of cardiovascular diseases

Publications

Aucubin Protects against Myocardial Infarction-Induced Cardiac Remodeling via nNOS/NO-Regulated Oxidative Stress, Yang Z, 2018
Sesamin prevents apoptosis and inflammation after experimental myocardial infarction by JNK and NF-κB pathways, Yang Z, 2017
Cucurbitacin B Protects Against Pressure Overload Induced Cardiac Hypertrophy, Yang Z, 2017
Sesamin Protects Against Cardiac Remodeling Via Sirt3/ROS Pathway, Yang Z, 2017
A potential therapeutic approach to cardiac remodeling: JDP2, Yang Z, 2018
Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy, Yang Z, 2016
Naringenin attenuates pressure overload-induced cardiac hypertrophy, Yang Z, 2015
Hesperetin attenuates mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2 cardiomyocytes, Yang Z, 2014
TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis, Yang Z, 2019
TLR9 deficiency alleviates doxorubicin-induced cardiotoxicity via the regulation of autophagy, Yang Z, 2020
The Role of PPARs in Pathological Cardiac Hypertrophy and Heart Failure, Yang Z, 2017
Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis, Yang Z, 2016
Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway, Yang Z, 2016
Mechanisms contributing to cardiac remodelling, Yang Z, 2017
BMI1 in the heart: Novel functions beyond tumorigenesis, Yang Z, 2021
The Roles of Noncardiomyocytes in Cardiac Remodeling, Yang Z, 2020
Critical roles of macrophages in pressure overload-induced cardiac remodeling, Yang Z, 2021
6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway, Yang Z, 2021

Heart Failure Cardiac Remodeling Pathophysiology Clinical Prevention Interventional Diagnosis Cardiovascular Diseases Treatment Cardiology Research Clinical Practice

Mingwei Bao - Wuhan University

Yanhong Tang - Wuhan University

Wei Deng - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us